Extended-release formulations using microspheres, in situ gelling systems, and implantable devices can provide weeks to months of therapeutic coverage from a single administration
V.HouL.StrassbergZ.et al (2016)
If orforglipron receives approval for obesity in April 2026, it will enter a market that Morgan Stanley estimates could reach $100 billion annually by the early 2030s, potentially transforming Eli Lilly's already dominant position in the metabolic disease space
Fat Metabolism: By facilitating the use of fat for energy, it plays a role in how the body utilizes and stores fat
The result was Barre and the first studio opened in 1959 in her London basement
This elevated intracellular glutathione is not a sign of health, but rather a massive, desperate compensatory response